Acadia Pharmaceuticals reported $-113016000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -113.02M 68.36M
ALKERMES ALKS:US -26585000 28.97M
Alnylam Pharmaceuticals ALNY:US $ -146.73M 47.83M
Aptinyx Inc APTX:US $ -19379000 207K
Biogen BIIB:US $ 610.7M 23.6M
Biomarin Pharmaceutical BMRN:US $ 137.33M 203.21M
Bristol Myers Squibb BMY:US $ 2553M 90M
Cara Therapeutics CARA:US $ -27911000 5.61M
Corcept Therapeutics CORT:US $ 26.77M 9.9M
Cytokinetics CYTK:US $ -80.55M 58.85M
Eisai 4523:JP Y -20803M 34451M
Eli Lilly And LLY:US $ 2404.3M 487.1M
Intercept Pharmaceuticals ICPT:US $ -10.27M 10.59M
Intra Cellular Therapies ITCI:US $ -72.66M 13.34M
Johnson & Johnson JNJ:US $ 5862M 1026M
Marinus Pharmaceuticals MRNS:US $ -16.71M 10.4M
Moderna Inc MRNA:US 4.23B 1.18B
Neurocrine Biosciences NBIX:US $ 3.1M 39.4M
Pfizer PFE:US $ 9873M 5297M
Prothena PRTA:US -37944000 4.85M
Ptc Therapeutics PTCT:US $ -86.52M 1.79M
Sarepta Therapeutics SRPT:US $ -86.88M 18.93M
Seattle Genetics SGEN:US $ -133.05M 39.02M
Ultragenyx Pharmaceutical RARE:US $ -136.63M 34.07M
Vanda Pharmaceuticals VNDA:US $ -7.67M 16.3M
Vertex Pharmaceuticals VRTX:US $ 1040.9M 163.18M
YTE INCY:US $ 116.54M 5.81M